89bio Announces Appointment of Kathy LaPorte to its Board of Directors by Carolyn Helms | Nov 3, 2021 | Portfolio News
Nalu Medical Named Best MedTech Company and Medical Device in Field of Neurology by Carolyn Helms | Nov 2, 2021 | Portfolio News
Theseus Pharmaceuticals Announces FDA Clearance of Investigational New Drug Application for THE-630, a Pan-Variant KIT Inhibitor in Development for the Treatment of Gastrointestinal Stromal Tumors (GIST) by Carolyn Helms | Nov 1, 2021 | Portfolio News
Talaris Therapeutics Announces Initiation of Phase 2 Clinical Trial of FCR001 in Delayed Tolerance Induction by Carolyn Helms | Oct 29, 2021 | Portfolio News
Vaxcyte Appoints Carlos Paya and Michael Kamarck to Its Board of Directors by Carolyn Helms | Oct 28, 2021 | Portfolio News
